HirotakaKomaba Tokai University School of MedicineJapan

Hirotaka Komaba is a professor in the Department of Nephrology, Endocrinology and Metabolism at Tokai University School of Medicine. He received his MD from Kobe University School of Medicine and his PhD from Kobe University Graduate School of Medicine, where he trained under the mentorship of Dr. Fukagawa. After transferring to Tokai University School of Medicine, he spent 2 years at the Division of Bone and Mineral Research at Harvard School of Dental Medicine, where Dr. Lanske supervised his research. His primary research focus has been on CKD-MBD and the FGF23-Klotho axis. He has authored more than 60 original articles and 40 reviews published in KI, CJASN, AJKD, NDT, JCEM, JBMR, JCSM, Nature Reviews Nephrology, and Cell Metabolism, among others. He received the "Kimoto Award" from the Japanese Society for Dialysis Therapy in 2011, was inducted into the AJKD Reviewer's Hall of Fame in 2019, and received the "Clinical Scientist Award" from the Japanese Society of Nephrology in 2022. He was a member of the 2012 CKD-MBD Guideline Working Group of the Japanese Society for Dialysis Therapy and also served on the Steering Committee of the KDIGO Controversies Conference on CKD-MBD held in Madrid in 2023.

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
ElianaDina-Batlle Chairperson Dradina@mac.comHospital Metropolitano De Santiago Pontificia Universidad Católica Madre y MaestraDominican Republic
GustavoLaham Chairperson glaham@cemic.edu.arGustavo Laham, Sociedad Argentina de Nefrología (SAN)Argentina
OlynkaVega Chairperson olynkavega@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
  • Updates on Uremic Toxins
    ZiadMassy Speaker ziad.massy@apr.aphp.frGlobal Medical Director, AURA, Paris France
  • Bringing Nobel Prize Winning Discoveries in Oxygen Sensing to Nephrology Clinics
    Kai-UweEckardt Speaker kai-uwe.eckardt@charite.deDepartment of Nephrology and Medical Intensive CarGermany
  • A Look Forward: Clinical Implications of Translational Research in CKD-MBD
    HirotakaKomaba Speaker hkomaba@tokai-u.jpTokai University School of MedicineJapan
  • Challenges and Opportunities for Translating Anti-inflammatory Therapeutics into Treatments for Patients With Kidney Failure
    LauraDember Speaker ldember@pennmedicine.upenn.eduUniversity of Pennsylvania United States
  • Q/A
Hall E